117 related articles for article (PubMed ID: 25557642)
1. Hemangioma Activity and Severity Index (HASI), an instrument for evaluating infantile hemangioma: development and preliminary validation.
Semkova K; Kazandjieva J; Kadurina M; Tsankov N
Int J Dermatol; 2015 Apr; 54(4):494-8. PubMed ID: 25557642
[TBL] [Abstract][Full Text] [Related]
2. Infrared thermography to assess proliferation and involution of infantile hemangiomas: a prospective cohort study.
Mohammed JA; Balma-Mena A; Chakkittakandiyil A; Matea F; Pope E
JAMA Dermatol; 2014 Sep; 150(9):964-9. PubMed ID: 25073587
[TBL] [Abstract][Full Text] [Related]
3. Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS).
Janmohamed SR; de Waard-van der Spek FB; Madern GC; de Laat PC; Hop WC; Oranje AP
Clin Exp Dermatol; 2011 Oct; 36(7):715-23. PubMed ID: 21933230
[TBL] [Abstract][Full Text] [Related]
4. Measuring the severity of infantile hemangiomas: instrument development and reliability.
Haggstrom AN; Beaumont JL; Lai JS; Adams DM; Drolet BA; Frieden IJ; Garzon MC; Holland KE; Horii KA; Lucky AW; Mancini AJ; Metry DW; Morel KD; Newell BD; Nopper AJ; Siegel D; Swigonski NL; Cella D; Chamlin SL
Arch Dermatol; 2012 Feb; 148(2):197-202. PubMed ID: 22351819
[TBL] [Abstract][Full Text] [Related]
5. Inter-rater reliability of the Hayes Ability Screening Index in a sample of Australian prisoners.
Young JT; van Dooren K; Lennox NG; Butler TG; Kinner SA
J Intellect Disabil Res; 2015 Nov; 59(11):1055-60. PubMed ID: 26018331
[TBL] [Abstract][Full Text] [Related]
6. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Infantile Hemangiomas Using a Handheld Wireless Diffuse Optical Spectroscopic Device.
Fong CJ; Garzon MC; Hoi JW; Kim HK; Lauren CT; Morel K; Geller L; Antonov N; Weitz N; Wu J; Hielscher AH
Pediatr Dermatol; 2017 Jul; 34(4):386-391. PubMed ID: 28548465
[TBL] [Abstract][Full Text] [Related]
8. The Infantile Hemangioma Referral Score: A Validated Tool for Physicians.
Léauté-Labrèze C; Baselga Torres E; Weibel L; Boon LM; El Hachem M; van der Vleuten C; Roessler J; Troilius Rubin A
Pediatrics; 2020 Apr; 145(4):. PubMed ID: 32161112
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
Goldfarb N; Lowes MA; Butt M; King T; Alavi A; Kirby JS
Br J Dermatol; 2021 May; 184(5):905-912. PubMed ID: 32969027
[TBL] [Abstract][Full Text] [Related]
10. Growth characteristics of infantile hemangiomas: implications for management.
Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.
Chamlin SL; Mancini AJ; Lai JS; Beaumont JL; Cella D; Adams D; Drolet B; Baselga E; Frieden IJ; Garzon M; Holland K; Horii KA; Lucky AW; McCuaig C; Metry D; Morel KD; Newell BD; Nopper AJ; Powell J; Siegel D; Haggstrom AN
J Invest Dermatol; 2015 Jun; 135(6):1533-1539. PubMed ID: 25615551
[TBL] [Abstract][Full Text] [Related]
12. Infantile and congenital hemangiomas.
Liang MG; Frieden IJ
Semin Pediatr Surg; 2014 Aug; 23(4):162-7. PubMed ID: 25241092
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of reliability and validity of the Walking Index for Spinal Cord Injury II (WISCI-II) in children and adolescents with spinal cord injury.
Calhoun CL; Mulcahey MJ
J Pediatr Rehabil Med; 2012; 5(4):275-9. PubMed ID: 23411768
[TBL] [Abstract][Full Text] [Related]
14. Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment.
Mull JL; Chamlin SL; Lai JS; Beaumont JL; Cella D; Rancour EA; Baselga E; Haggstrom AN
Pediatr Dermatol; 2017 Jan; 34(1):78-83. PubMed ID: 27981617
[TBL] [Abstract][Full Text] [Related]
15. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
16. Infantile hemangioma: Predicting proliferation by infrared thermography.
Strumila A; Kazlauskas V; Pošiūnas G; Verkauskas G; Beiša V
Medicina (Kaunas); 2017; 53(2):85-89. PubMed ID: 28457717
[TBL] [Abstract][Full Text] [Related]
17. Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.
Dubcenco E; Zou G; Stitt L; Baker JP; Jeejeebhoy KN; Kandel G; Kim YI; Grover SC; McDonald JW; Shackelton LM; Khanna R; D'Haens G; Sandborn WJ; Feagan BG; Levesque BG
J Crohns Colitis; 2016 Sep; 10(9):1006-14. PubMed ID: 27385400
[TBL] [Abstract][Full Text] [Related]
18. Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
Suh KY; Frieden IJ
Arch Dermatol; 2010 Sep; 146(9):971-6. PubMed ID: 20855695
[TBL] [Abstract][Full Text] [Related]
19. Utility of the Infantile Hemangioma Referral Score (IHReS) as a decision-making tool for referral to treatment.
Chitpiromsak K; Techasatian L; Jetsrisuparb C
BMJ Paediatr Open; 2021; 5(1):e001230. PubMed ID: 34604545
[TBL] [Abstract][Full Text] [Related]
20. Early growth of infantile hemangiomas: what parents' photographs tell us.
Tollefson MM; Frieden IJ
Pediatrics; 2012 Aug; 130(2):e314-20. PubMed ID: 22826568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]